AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Risk Prevention Program and Therapeutic Patient Education Program of Patients With Uncontrolled Epilepsy

RecruitingNAAges 18 Years - 60 YearsAllUniversity Hospital, Montpellier
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Pilot, controled, randomized study aiming to evaluate a plan for the prevention of risks related to epilepsy, 3 months after the last therapeutic patient education session. Two groups of patients will be compared: group "intervention" (consultation with the neurologist then a psychologist followed by a session dedicated to risk prevention ("Recognize and Manage risks") integrated into usual Therapeutic Patient Education (TPE) versus "control" group (usual consultations with the neurologist and usual TPE). 37 subjects per group will be included in this study.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patient between 18 and 60 years old * Patient with poorly controlled epilepsy (persistence of seizures evolving for more than a year despite proper treatment) or patient seizure-free for over a year but for whom therapeutic patient education (TPE) would be beneficial according to the investigator.. * Patient agreeing to participate in a therapeutic education program (TPE) Exclusion Criteria: * Epileptic patient who has already benefited from a TPE epilepsy program * Patients with major cognitive impairment * Patient under guardianship or legal protection (safeguard of justice) * Pregnant or breast-feeding women * Failure to obtain written informed consent after a reflection period * Patient who for geographical, social or psychological reasons could not participate in the research * Any situation that, in the opinion of the investigator, could present risks to the patient and to the research * Participation in another therapeutic research * Subjects not covered by public health insurance
๐Ÿ’Š

What it tests

  • Risk prevention session
  • Usual Therapeutic Patient Education (TPE) management
๐Ÿ“

Where

2 sites
CHU Gui de Chauliac
Montpellier, France
CHU de Toulouse
Toulouse, France
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy